Regenerative framework for post‑viral polyneuropathy
Guillain‑Barré Syndrome (GBS) is an acute, immune‑mediated peripheral nerve disorder often triggered by viral infection. In the post‑inflammatory phase, residual nerve damage, muscle weakness, and functional limitations persist. Our clinical framework integrates umbilical cord mesenchymal stem cells (UC‑MSC) to modulate the neural microenvironment: MSCs secrete neurotrophic factors (BDNF, GDNF, NGF) and anti‑inflammatory cytokines, shifting macrophages toward a repair phenotype. This paracrine activity supports axonal preservation and Schwann cell function. Physical therapy and tailored nutritional medicine serve as complementary pillars to enhance neuromuscular re‑education and reduce oxidative stress. All techniques are minimally invasive and administered under rigorous clinical governance.
This framework is rooted in regenerative science, focusing on endogenous repair dynamics. We do not describe the intervention as a cure, but as a biological strategy to improve nerve signaling, muscle reinnervation, and overall quality of life. Each case undergoes individualized assessment.
Patient's Guide
General guide: GBS pathology, MSC mechanisms, physical rehabilitation principles, and nutritional strategies. 22 pages, evidence‑based.
We respect your privacy. No spam.
Umbilical mesenchymal stem cells: biological rationale for GBS
Umbilical cord derived mesenchymal stem cells (UC‑MSC) exhibit immunomodulatory properties and secrete neurotrophic factors such as BDNF, NGF, and GDNF. In the context of GBS, intravenous or intrathecal administration is performed to support a regenerative neural environment. Preclinical models demonstrate UC‑MSC promote macrophage polarization toward a repair phenotype and enhance Schwann cell activity. Our clinical practice applies these cells under strict release criteria, combined with physical medicine to consolidate functional gains. (PubMed: MSC rationale in peripheral neuropathy)
Nutritional medicine targets mitochondrial support and myelin maintenance: specific nutrition protocols are tailored for each patient. All interventions are performed with minimally invasive techniques, prioritizing safety and biological plausibility.
Learn Moreumbilical cord MSC · neural immunomodulation
Important clinical note: This adjunctive supportive approach is not a replacement for standard Guillain‑Barré treatments (such as IVIG, plasmapheresis, corticosteroids, or conventional physical therapy). Patients should continue those treatments under the direction of their prescribing physician.
Medically reviewed by Dr. Guillermo Quezada, MD – May 2026 (regenerative medicine specialist) | Content reviewed as of March 2026
MSC therapy for Guillain‑Barré Syndrome / post‑viral nerve damage is not approved by the U.S. FDA, Mexican COFEPRIS (for this indication), or any other regulatory agency. It is considered an adjunctive, experimental procedure.
Costs are discussed only after a consultation.
Begin Your Neurological Recovery Journey
Complete your consultation request in minutes. Our specialists are ready to help you regain function and neuromuscular health.
Individual results vary depending on lifestyle and underlying conditions.
Request a Neurological Consultation
Our regenerative medicine team is ready to evaluate your needs
Individual results vary depending on lifestyle and underlying conditions.